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Summary Cell killing can be achieved in an acidic environment in tissue culture (medium pH <7.0) by agents
(nigericin, carbonylcyanide-3-chlorophenylhydrazone (CCCP)) which transport protons from the extracellular
space into the cytoplasm. Cell killing is enhanced when these agents are used in combination with compounds
(amiloride, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS)) which inhibit the membrane-based
exchangers responsible for the regulation of intracellular pH (pHi). We describe experiments which assess the
ability of these agents to kill tumour cells in spheroids and in vivo. Both nigericin and CCCP were observed to
penetrate tissue based on their ability to kill tumour cells in spheroids. The mean extracellular pH (pHe) of the
KHT fibrosarcoma and the EMT-6 sarcoma were observed to be 0.21 and 0.32 pH units more acidic than the
mean pHe in muscle tissue. Intraperitoneal (i.p.) administration of the vasodilator hydralazine (1Omgkg')
caused a reduction of the mean pHe of the KHT but not the EMT-6 tumour. Nigericin (2.5 mg kg-', i.p.) plus
amiloride (10mg kg-', i.p.) followed 30min later by hydralazine (10mg kg-, i.p.) reduced the surviving
fraction of cells in the KHT and EMT-6 tumours, but had minimal effects on growth delay. When KHT
tumours were treated with 15 Gy X-rays followed immediately by nigericin plus amiloride and hydralazine a
reduced surviving fraction as well as an increase in tumour growth delay was observed compared to radiation
alone. The administraion of nigericin (2.5 mgkg', i.p.) or the combination of nigericin (2.5 mgkg', i.p.)
followed by hydralazine (10 mgkg-', intravenous (i.v.)) resulted in reductions of tumour pHi of 0.27 and
0.29 pH units respectively as determined by 31P magnetic resonance spectroscopy (MRS). Our results show
that the combination of nigericin and hydralazine (with or without amiloride) can kill cells in rodent solid
tumours and that cell killing is associated with a reduction in the mean pHi of tumour cells.
The pH of solid tumours has been determined by using
pH-sensitive microelectrodes which measure predominantly
pHe, and by using 3"P-MRS which measures primarily pHi
(Wike-Hooley et al., 1984; Vaupel et al., 1989). Values of
pHe in solid tumours extend over a broad range (median
6.9-7.0) and are on average approximately 0.5 pH units
more acidic than normal tissue pHe (median 7.4-7.5) (Wike-
Hooley et al., 1984). Intracellular pH in solid tumours has
been observed to have a wider range than that in normal
tissue but median pHi (7.2) does not appear to be signifi-
cantly lower in solid tumours as compared to normal tissue
(Vaupel et al., 1989). Taken together these results indicate
that cells in solid tumours are surrounded by an acidic
extracellular fluid and that tumour cells are actively
regulating their pHi to physiological levels. Since the above
techniques have poor spatial resolution, it seems probable
that microenvironments exist within solid tumours which are
more acidic than the observed median value of pHe.
As solid tumours enlarge, deficient vascularisation as com-
pared to normal tissue usually results in poor delivery of
oxygen to many regions within them (Thomlinson & Gray,
1955; Tannock, 1968). Cells in a hypoxic microenvironment
are dependent on anaerobic glycolysis for energy production
and consequently produce large amounts of lactic acid.
Glycolytic activity resulting in lactic acid production is
thought to be a cause of tumour acidity (Wike-Hooley et al.,
1984; Tannock & Rotin, 1989; Vaupel et al., 1989). However,
in recent experiments from this laboratory tumours were
generated from glycolysis-deficient variant cells which
developed an acidic microenvironment in the absence of
lactate production (Newell et al., unpublished observation).
Regions ofhypoxia probably coexist with regions of low pHe
and possibly low pHi.
Hypoxic cells are known to be resistant to the effects of
ionising radiation (Moulder & Rockwell, 1984; Vaupel et al.,
1989). Cells at a distance from the vasculature may be resist-
ant to chemotherapy due to limited penetration of agents to
these cells, or the low proliferative rate of nutritionally-
deprived cells may render them insensitive to the effects of
drugs active against cycling cells (e.g. Tannock, 1982; Chap-
lin et al., 1985). Cells in a hypoxic/acidic microenvironment
may therefore represent a subpopulation of tumour cells
responsible for treatment failure. It might be possible to kill
selectively cells in an acidic microenvironment within solid
tumours by utilising the existing acidity to cause intracellular
acidification.
Most cellular processes have pH optima at or near physio-
logical pH (Trivedi & Danforth, 1966; Busa & Nuccitelli,
1984). The viability of cells in an acidic microenvironment
depends therefore on the activity of membrane-based
exchangers which regulate pHi (Rotin et al., 1989). When
cells are exposed to a low pHe environment, the Na+/H+
antiport (Grinstein et al., 1989) and the Na+-dependent
HCO3-/C1- exchanger (Cassel et al., 1988; Valbourg-
Reinertsen et al., 1988) are the two major membrane-based
exchangers involved in the regulation of pHi. The Na+/H+
antiport is inhibited by amiloride and the Na+-dependent
HCO3 /C1- exchanger is inhibited by stilbene derivatives
such as DIDS.
Our laboratory has shown that it is possible to kill selec-
tively cells in an acidic environment in vitro by using agents
which cause intracellular acidification. Intracellular acidifi-
cation leading to cell death was accomplished in vitro using
agents which transport H+ from the extracellular space into
the cytoplasm and this effect was enhanced by agents which
inhibit the membrane-based mechanisms which regulate pHi.
The ionophore nigericin (Rotin et al., 1987), which is capable
of exchanging intracellular K+ for extracellular H+, or
CCCP (Newell & Tannock, 1989), which is capable of trans-
porting H+ equivalents into cells, as well as the weak acid
succinate (Dobrowsky et al., 1991), were cytotoxic to tumour
cells in vitro only at pHe<6.5. When nigericin or CCCP was
combined with amiloride and/or the stilbene derivative DIDS,
agents which inhibit the membrane-based exchangers respon-
sible for the regulation of pHi, cytotoxicity was observed at
pHe<7.0. In these in vitro studies cytotoxicity was
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associated with the ability to produce intracellular
acidification.
The objective of the present study was to determine if
agents which produce intracellular acidification and are selec-
tively toxic at low pHe in vitro have anti-tumour effects
against two murine transplantable tumours.
Materials and methods
Cells
At the Ontario Cancer Institute, the KHT fibrosarcoma and
the EMT-6 murine sarcoma cells were maintained in vitro in
a-minimum essential medium (a-MEM) supplemented with
10% foetal bovine serum (FBS) and 0.1 mgml-' kanamycin
(complete medium). Both cell lines were maintained in cul-
ture for eight passages and then were passaged in syngeneic
hosts. Routine tests for mycoplasma revealed that the cell
lines were free from contamination. Tumour cells were dis-
carded at 4-6 months intervals and re-initiated from frozen
stock.
Spheroids
Spheroids were used in some experiments as a model of
intermediate complexity between single cells and solid
tumours to assess the ability of our agents to penetrate into
tissue. Spheroids were grown from EMT-6 murine sarcoma
cells. EMT-6 spheroids were initiated by seeding 104
cells ml-1 in 15 ml of complete medium in a non-tissue cul-
ture treated plastic dish. After 4 days cell aggregates were
transferred into spinner flasks containing 200 ml of a-MEM
minus bicarbonate supplemented with 25 mM hydroxyethyl-
piperazine-N'-2-ethanesulfonic acid (Hepes) (pH 7.4), 10%
FBS and 0.1 mgml-' kanamycin (spheroid medium). Medium
was changed every 48 h. Spheroid diameter was determined
by measuring orthogonal diameters of a minimum of 30
spheroids and then determining a geometric mean diameter
for the growing population. Spheroids were used for
experiments when they had attained a mean diameter of
approximately 800 jim.
To assess cell survival following exposure to potentially
toxic agents, spheroids were washed once with a-MEM plus
10% FBS buffered with bicarbonate/2[N-morpholino]-ethane-
sulfonic acid (Mes) (25 mM) to the desired pH and placed in
50 ml spinner flasks containing the same medium (Newell &
Tannock, 1989). Spinner flasks were placed in a 37°C water
bath and humidified 5% C02/95% air was continuously
flowed over the suspensions (Whillans & Rauth, 1980).
Medium pH drifted a maximum of 0.1 pH units during the
exposure period. After 30 min equilibration, drugs were
added. Samples were taken and spheroids were washed once
with fresh complete medium and disaggregated by trypsinisa-
tion (0.05% trypsin in 0.53 mM ethylenediaminetetraacetic
acid (Gibco; Grand Island, New York)) for 20 min at 37°C.
The resulting single cell suspensions were counted electroni-
cally, diluted and plated in triplicate. After 11 days plates
were stained and colonies containing greater than 50 cells
were counted.
Tumours
At the Ontario Cancer Institute, the KHT fibrosarcoma and
the EMT-6 sarcoma were propagated in 8-12 week old
inbred female C3H/HeJ and BALB/c BYJ mice respectively.
Mice were purchased from Jackson Laboratories (Bar Har-
bour, Maine). Tumours were initiated by intramuscular injec-
tion of 2.5-5.0 x 105 cells into the left hind leg. Growth of
tumours was monitored by passing the tumour-bearing leg
through a strip of lucite with graded size holes. The diameter
of the tumour-bearing leg was converted to an estimate of
tumour weight using a previously defined calibration curve.
Tumours were used for experiments when they had attained
0.3-0.5 g in weight, which required approximately 9 days for
both tumour types.
The subline of the KHT fibrosarcoma that was used for
studies of magnetic resonance spectroscopy (MRS) at the
MRC Unit, UK was maintained by i.m. in vivo passage in
C3H mice, with return to frozen stock after 15-20 passages.
For MRS experiments tumours were generated by injecting a
single cell suspension containing approximately 2 x 105 cells
intradermally on the back of the mouse. Tumours were
studied after approximately 10 days growth, when they had a
diameter of 6-8 mm.
Measurement oftumourpHe
Mice were anaesthetised with tribomoethanol 0.50 mgkg-'
mouse weight (Avertin). Measurements of pHe were made
using a miniature glass electrode (model MI-408B, Microelec-
trodes Inc.) against a silver-silver chloride reference electrode
(model MI-402, Microelectrodes Inc.) using a portable pH
meter (model pH 103, Corning). The reference electrode was
inserted subcutaneously on the back and the pH electrode
was inserted directly into the tumour or muscle after incising
the overlying skin. Measurements of tumour pHe were made
at increments of 50-75jim along a single track at a depth of
300-500jim into the tumour by using a specially constructed
micrometer to advance the electrode. A mean of 6 and a
minimum of 4pHe measurements were made per tumour.
Drugs
CCCP, nigericin, amiloride, hydralazine and all other
chemicals were purchased from Sigma (St. Louis, Missouri).
Mice were injected with various combinations of CCCP dis-
solved in 10% ethanol, nigericin dissolved in 10% ethanol,
amiloride dissolved in sterile water, and hydralazine dissolved
in sterile water. Nigericin was prepared and stored in glass
vials due to its known ability to bind to plastic (Varnes et al.,
1989). All drugs were delivered i.p. in a volume of0.01 mgg-'
body weight except for 3'P-MRS experiments when hydra-
lazine was administered i.v. Radiation was delivered to the
tumour-bearing limb of unanaesthetised mice restrained in a
specially designed jig. The radiation source was a double-
headed 100 kVp X-ray unit which has a dose rate of
10.2 Gymin-'.
Excision assay
Tumours were excised 20-24 h after treatment, weighed and
then minced with scissors in phosphate buffered saline (PBS).
Single cell suspensions were prepared by enzymatic digestion
with trypsin (Difco) and DNAse I (Sigma) (Thomson &
Rauth, 1974). Tumour cell suspensions were stained with
trypan blue and dye-excluding cells were counted with a
haemocytometer. Tumour cell suspensions were then diluted
and plated in triplicate in complete medium. Plates were
stained 11 days later and colonies containing greater than 50
cells were counted. Surviving fraction per tumour was cal-
culated according to: SF/tumour = (plating efficiency treated/
plating efficiency control) x ((cells/gram treated)/(cells/gram
control)).
Growth delay assay
Mice bearing tumours in the range of 0.3-0.5 g (8.5-9.5 mm
leg diameter) were identified with ear tags and randomly
distributed into treatment groups (minimum five mice per
group). Mice were treated and leg diameters were recorded to
the nearest 0.5 mm every 2-3 days by an observer who was
unaware of the treatment history. Measurements were con-
verted to estimates of tumour weight, and growth curves
were compared for treated and control tumours. Mice were
killed humanely when tumours attained a weight of approxi-
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Tumour 3'P-MRS measurements
Unanaesthetised mice bearing intradermal KHT tumours were
restrained in a specially designed jig. MRS experiments were
performed using a 4.7 Tesla 30 cm horizontal bore magnet
(Oxford Instruments), interfaced with a SISCO 200 spectro-
meter. A 7 mm surface coil was placed over the tumour for
Rf transmission and signal collection. Acquisition parameters
were set to minimise contamination from underlying tissue.
Each spectrum consisted of 256 scans with a 2 s delay time,
giving a total collection time of approximately 7 min per
spectrum. Spectra from a single undistributed mouse were
recorded at 15 min intervals up to 120 min after drug
administration. Values of pHi were calculated by examining
the change in the chemical shift of the inorganic phosphate
peak relative to a-ATP and y-ATP peaks. Since phospho-
creatine was not present in the spectra of every tumour, this
peak was not used to calculate pHi.
Results
Spheroid toxicity
EMT-6 spheroids were exposed to concentrations of CCCP
(1I5pM) and nigericin (3.4,UM) which had been shown previ-
ously to be toxic to single cell suspensions (Rotin et al., 1987;
Newell & Tannock, 1989). Cell killing was not observed for
spheroids exposed to CCCP or nigericin at pH 7.4, or
spheroids exposed to low pHe (6.4) in the absence of
ionophores (Figure 1). A time dependent decrease in surviv-
ing fraction was observed for spheroids exposed to CCCP or
nigericin at pHe 6.4 (Figure 1), indicating that both drugs






The mean values of pHe in KHT (6.84) and EMT-6 (6.75)
tumours were observed to be significantly more acidic than
the mean pHe of muscle (7.06) (Table I). Since the in vitro
cytotoxicity of the compounds to be tested increased sharply
at lower values of pHe, we attempted to decrease selectively
tumour pHe by the i.p. administration of the vasodilator
hydralazine, which has been shown to cause large transient
increases in the hypoxic fraction of rodent solid tumours
(Chaplin & Acker, 1987; Chaplin, 1989; Dunn et al., 1989).
Forty-five minutes after hydralazine treatment there was a
small increase in the pHe differential between tumour and
muscle tissue for both tumour types (Table I). For KHT
tumours, tumour pHe was reduced and muscle pHe remained
the same, whereas for EMT-6 tumours, tumour pHe remained
the same and muscle pHe was increased.
Effect ofnigericin andhydralazine on tumourpHi
No reduction in pHi in KHT tumours was observed in control
mice injected with PBS (Figure 2) or with hydralazine
(10mg kg-', i.v.) (data not shown). Nigericin (2.5 mg kg-',
i.p.) caused a significant reduction in pHi with a maximum
decrease of 0.27pH units occurring 45 min after injection
(Figure 2). The combination of nigericin followed by hydra-
lazine was observed to cause a similar decrease in pHi (maxi-
mum 0.29 pH units) with a trend to a more prolonged period
of acidification (Figure 2).
CCCP
The dose of CCCP which could be administered to mice was
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Figure 1 Surviving fraction of cells from EMT-6 spheroids.
Spheroids were exposed to the following conditions pH 7.4, 6.4
(data not shown), pH 7.4, 6.4 plus 15 tLM CCCP (OH,), and
pH 7.4, 6.4 plus 3.4 jLM nigericin (A,A). No decrease in surviving
fraction was observed for spheroids exposed to pH 7.4 or pH 6.4
in the absence of ionophores. Points represent mean and range
from one experiment (range of values less than vertical extent of
symbols). Qualitatively similar results have been obtained in a
repeat experiment.
Figure 2 The effect of PBS (0), nigericin (2.5 mg kg-') (0),
and nigericin (2.5mg kg-') and hydralazine (1Omg kg-') (A) on
pHi in KHT tumours as determined by 3'P-NMR. Points and
error bars represent mean ± standard error from at least six
tumours.
Table I Effect of hydralazine on tumour pHe
pHe 45 min
pHe after hydralazine (10mgkg-')
Tissue KHT EMT-6 KHT EMT-6
Muscle 7.05 (0.08)a 7.07 (0.08) 7.05 (0.08) 7.21 (0.04)
Tumour 6.84 (0.06) 6.75 (0.06) 6.64 (0.11) 6.82 (0.08)
ApHe 0.21 (0.1O)b 0.32 (0.10) 0.41 (0.14) 0.39 (0.09)
aValues represent mean ± s.e.mean from at least six tumours.
bApHe = (mean muscle pHe-mean tumour pHe).
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water containing 10% ethanol. A dose of 1.0 g kg-' CCCP
was well tolerated alone or in combination with 1Omg kg'
amiloride and/or 10 mg kg- I hydralazine. Similar results
were obtained when CCCP was dissolved in alternative
solvents such as dimethylsulfoxide and N-N-dimethylaceta-
mide.
Treatment of KHT tumours with CCCP plus amiloride
followed 30 min later by hydralazine alone or in combination
with 15 Gy X-rays did not lead to a decrease in surviving
fraction per KHT tumour in excision assays (data not
shown). No growth delay was observed for mice treated with
CCCP plus amiloride followed by hydralazine either when
these three agents were given alone, or in combination with
15 Gy X-rays (data not shown).
radiation (mean 12.3 days) as compared to radiation alone
(mean 7.5 days) (Table III).
Discussion
The results from this study indicate that the ionophore
nigericin, which produces pHe-dependent cytotoxicity via in-
tracellular acidification in vitro, is capable of killing cells in
murine solid tumours.
Microelectrode measurements of pHe within spheroids
have shown that pHe decreases as distance from the spheroid
surface increases (Acker et al., 1987; Carlson & Acker, 1988).
In medium at pH 7.4, minimum pHe at a depth of 200 gm
Nigericin
The maximum tolerated dose of nigericin dissolved in sterile
water containing 10% ethanol was approximately 4.0 mg kg-'
alone and approximately 2.5mg kg-' in combination with
amiloride (10 mg kg-') and/or hydralazine (10 mg kg-').
Maximum tolerated dose was defined as the dose of drug
which did not cause animal death within 30 days.
After excision of tumours the number of dye-excluding
tumour cells per gram of tumour tissue was determined. It
was observed that only nigericin followed by hydralazine or
nigericin plus amiloride followed by hydralazine caused
significant decreases in the number of dye-excluding cells per
gram of tumour recovered (Table II). A similar reduction in
cell recovery was observed when drugs were combined with
15 Gy X-rays (Table II). These conditions also led to a
decrease in surviving fraction per tumour (Table II). The
decrease in surviving fraction per tumour caused by the drug
combination appeared to be additive to the decrease in sur-
viving fraction per tumour caused by radiation. Similar
effects were observed for the EMT-6 tumour (data not
shown).
The decrease in surviving fraction per tumour for nigericin
followed by hydralazine was observed to be dependent on the
dose of nigericin (Figure 3a) and on the dose of hydralazine
(Figure 3b). A decrease in surviving fraction per tumour was
observed when hydralazine was administered 3 h prior to or
3 h after nigericin plus amiloride (Figure 4). Maximum
reduction in surviving fraction per tumour was observed
when hydralazine was administered from 1 h before to 1 h
after nigericin.
The effects of nigericin plus amiloride followed by hydra-
lazine on tumour growth delay are presented in Figure 5.
When used alone these agents did not lead to a significant
delay in tumour growth. When used with radiation, no addi-
tional growth delay was observed for EMT-6 tumours,
whereas for the KHT tumour there was a trend to increased
growth delay when drugs were used in combination with
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Figure 3 a, The effect of the dose of nigericin on surviving
fraction per KHT tumour for mice treated with the indicated
dose of nigericin followed 30 min later by hydralazine
(1Omg kg'). b, The effect of the dose of hydralazine on the
surviving fraction per KHT tumour. Mice were treated with
nigericin (2.5 mg kg-') followed 30 min later by the indicated
dose of hydralazine. Points and error bars represent mean and
range from at least two experiments.
Table II Number of dye excluding cells (x 10-7) recovered per gram of tumour and
surviving fraction per tumour for the KHT tumour
Drugs alone Drugs plus 15 Gy X-rays
# cells S.F. per # cells S.F. per
Treatment per gram tumour per gram tumour
Control 7.7 1.0 4.8 2.6 x 10-2
(6.9-12.0) (0.85-1.0) (2.5-8.2) (2.1-3.0 x 10-2)
Nigericin + 7.3 0.73 6.2 2.7 x 10-2
Amiloride (4.0-10.1) (0.82-0.64) (2.0-10.4) (2.5-2.8 x 10-2)
Hydralazine 9.0 0.70 7.7 1.2 x 10-2
(7.9- 10.1) (0.62-0.82) (6.4-9.0) (0.9-2.5 x 10-2)
Nigericin 0.7 1.3 x 10-2
Hydralazine (0.5-1.0) (0.8-1.8 x 10-2)
Nigericin +
Amiloride-> 1.5 3.7 x 10-2 1.4 3.4 x 10-4
Hydralazine (0.7-2.2) (3.5-3.8 x 10-2) (0.9-1.9) (2.8-3.6 x 10-4)
Values represent mean (range) from at least two experiments.
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Figure 4 The effect of the time of hydralazine administration on
the surviving fraction per KHT tumour. Mice were treated with
nigericin (2.5 mg kg-') plus amiloride (1Omg kg-') and hydrala-
zine (1Omg kg-'), was given at the indicated time relative to the
other agents. Points and error bars represent mean and range
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Figure 5 Growth curves for EMT-6 a, and KHT b, tumours.
Mice were treated with control (0), nigericin (2.5 mg kg-') and
amiloride (10 mg kg-1) followed 30 min later by hydralazine
(10mg kg-') (0), 15 Gy X-rays (0), and 15 Gy X-rays plus
drugs (-). Points and error bars represent mean ± s.e. for at
least five tumours.
from the surface of spheroids has been observed to be ap-
proximately 6.8. Cell killing was not observed when EMT-6
spheroids were exposed to CCCP or nigericin at pHe 7.4.
Since CCCP and nigericin have been shown previously to be
selectively toxic at pHe's less than 6.5, the failure to observe
cell killing at pHe 7.4 was probably due to the fact that at
most a small proportion of cells within the spheroids had
ambient pHe within the range necessary for cytotoxicity of
CCCP or nigericin. When spheroids were incubated in
medium at low pHe and exposed to CCCP or nigericin, time
dependent cytotoxicity was observed with several orders of
magnitude of cell killing (Figure 1). This result demonstrates
that CCCP and nigericin are capable of penetrating into
tissue and killing cells.
The mean pHe in KHT (6.84) and EMT-6 (6.75) tumours
growing in the legs of mice was observed to be 0.21 and
0.32 pH units more acidic than muscle pHe (Table III). The
observed values of pHe for KHT and EMT-6 tumours are
consistent with those reported for other rodent solid tumours
(Wike-Hooley et al., 1984); however, mean values of pHe
within KHT and EMT-6 tumours were above the threshold
(pHe 6.5) for cytotoxicity by nigericin or CCCP alone (Rotin
et al., 1987; Newell & Tannock, 1989). Nigericin and CCCP
were therefore combined with the Na+/H+ exchange
inhibitor amiloride which has been shown to allow killing of
cells by CCCP and nigericin at values of pHe below 7.0.
We could not demonstrate in vivo toxicity of CCCP when
used in high concentration (1.0 g kg-' body weight) either
alone or in combination with other agents. The lack of
cytotoxicity for CCCP may have been due to the limited
solubility of CCCP in aqueous solutions which may prevent
CCCP from reaching toxic concentrations within tumours.
We have not performed pharmacological studies in an
attempt to address directly this possibility.
Nigericin combined with amiloride also was not cytotoxic
to KHT or EMT-6 tumours in excision assays or in growth
delay experiments. Failure to observe in vivo toxicity may
have been due to pHe values that were to( high to allow cell
killing at the doses achieved. We therefore used the
vasodilator hydralazine in an attempt to reduce tumour pHe.
Hydralazine has been shown previously to produce a dose-
dependent reduction in tumour blood flow (Chaplin, 1989;
Lin & Song, 1990). This decrease in tumour blood flow may
lead to a decrease in tumour pHe because the rate of
glycolysis may increase under induced anaerobic conditions,
leading to accumulation of lactic acid, and because of
reduced clearance of this and other metabolic acids. Hydrala-
zine caused a decrease in pHe of the KHT tumour with little
change in pHe of EMT-6 tumours. Our results with the
EMT-6 tumour are consistent with a previous study which
reported that hydralazine did not reduce pHe in RIF-I
tumours (Tobari et al., 1988).
When nigericin plus amiloride was combined with hydra-
lazine a decrease in surviving fraction was observed when the
agents were given alone or in combination with 15 Gy radia-
Table III Delay in growth of KHT and EMT-6 tumours following various
treatments
KHT EMT-6
Days Growth Days Growth
Treatment to 1 g delay to I g delay
Control 4.7 (1.0) - 5.5 (0.9)
Nigericin + Amiloride
Hydralazine 5.3 (0.5) 0.6 7.6 (1.3) 2.1
l5Gy X-rays 12.2 (1.5) 7.5 16.5 (1.4) 11.0
15Gy X-rays->
Nigericin + Amiloride+ 17.0 (4.6) 12.3 16.2 (1.3) 10.7
Hydralazine
The values for days to 1 g represent mean ± s.e. from two growth delay experiments.
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tion (Table II). The toxic effects of nigericin plus amiloride
followed by hydralazine appeared to be additive with those
of radiation, and do not suggest selective toxicity towards
nutritionally-deprived cells in hypoxic/acidic environments of
solid tumours. However, this result might also be obtained if
there was fluctuating hypoxia in the tumour (Minchinton et
al., 1990) such that cells which had regained sensitivity to
radiation had maintained an acidic microenvironment for a
sufficiently long period to render them drug-sensitive.
Nigericin plus amiloride followed by hydralazine alone or in
combination with 15 Gy X-rays had a minimal effect on
growth delay against the EMT-6 tumour (Table III).
Nigericin plus amiloride followed by hydralazine produced a
non-significant increase in the growth delay for the KHT
tumour (approximately 4.8 days) only when combined with
radiation (Table III). The apparent inconsistent effects when
comparing excision assay results to growth delay results may
be due to the modest decrease in surviving fraction per
tumour caused by nigericin plus amiloride followed by hy-
dralazine which may not be sufficient to produce a measurable
growth delay; in addition, there may be smaller effects of the
drugs to influence growth delay if they exert their effects
selectively against a slowly-proliferating nutrient-deprived
subpopulation of cells. In excision assays the decrease in
surviving fraction per tumour was due partly to a loss in the
number of cells recovered per tumour. Decreased cell
recovery may be due to rapid lysis of cells killed by the
acidifying agents, but may be influenced by the trypsinisation
procedure used to produce single cell suspensions. Disaggre-
gation may have led to lysis of already damaged cells, since
drug-damaged cells might be more susceptible to the effects
of trypsin. If such drt6g-induced damage were repairable, the
reduction in surviving fraction per tumour might have been
due in part to artifacts introduced by the trypsinisation
procedure. Although this study does not indicate that nigeri-
cin plus amiloride are selectively toxic to nutritionally-
deprived cells in solid tumours, it is encouraging that
nigericin plus amiloride followed by hydralazine can produce
tumour cell killing in vivo. Our results suggest that the ap-
proach ofattempting to utilise agents which produce intracel-
lular acidification may be useful if better tolerated and/or
more potent analogues of nigericin and amiloride become
available. In vivo studies with more potent analogues of
amiloride are in progress in our laboratory.
Hydralazine was able to potentiate cell killing by nigericin
and amiloride in both tumours although it decreased the
mean value of pHe only in the KHT tumour. Possible ex-
planations are (i) hydralazine may have reduced the pHe of
only a small proportion of tumour cells such that the mean
tumour pHe was not affected, (ii) nigericin combined with
amiloride is more active under hypoxic conditions (iii) a
direct interaction between hydralazine and nigericin plus
amiloride, and (iv) an effect of hydralazine to decrease blood
flow and delay clearance of other agents from the tumour.
These possibilities have not been addressed directly in this
study. For technical reasons, studies of tumour pHi using
P3'-MRS were undertaken on tumours that were implanted
intradermally on the backs of mice. Although we recognise
that this model is not identical to that used for studies of
anti-tumour effects against intra-muscularly implanted
tumours, we were able to demonstrate that nigericin could
lower pHi of tumours in vivo.
Neither PBS or hydralazine influenced tumour pHi (Figure
2) whereas nigericin or nigericin followed by hydralazine led
to reductions in tumour pHi of 0.27 and 0.29 pH units
respectively. These observations suggest that nigericin enters
tumour tissue and is capable of producing a reduction in
tumour pHi which may result in tumour cell cytotoxicity.
The present study provides evidence which indicates that
agents which cause intracellular acidification and cytotoxicity
at low pHe (<7.0) in vitro have small anti-tumour effects in
vivo. The cytotoxic effect in vivo appears to be associated
with the ability to produce intracellular acidification in vivo.
Studies are in progress (using more potent analogues of
amiloride) to determine if treatments are selectively toxic to
specific subpopulations of cells by using the technique of
Hoechst 33343 staining and fluorescence-activated cell sorting
(Durand, 1982; Chaplin et al., 1985).
This research was supported by a research grant from the Medical
Research Council of Canada. Investigations using magnetic
Resonance Spectroscopy were supported in part by the Imperial
Cancer Research Fund and British Technologies Group. K.N. is a
recipient of a National Cancer Institute of Canada Studentship.
References
ACKER, H., CARLSSON, J., HOLTERMANN, G., NEDERMAN, T. &
NYLEN, T. (1987). Influence of glucose and buffer capacity in the
culture medium on growth and pH in spheroids of human
thyroid carcinoma and human glioma origin. Cancer Res., 47,
3504.
BUSA, W.B. & NUCCITELLI, R. (1984). Metabolic regulation via
intracellular pH. Am. J. Physiol., 246, R409.
CARLSON, J. & ACKER, H. (1988). Relations between pH, oxygen
partial pressure and growth in cultured cell spheroids. Int. J.
Cancer, 42, 715.
CASSEL, D., SCHARF, O., ROTMAN, M., CRAGOE, E.J. & KATZ, M.
(1988). Characterization of the Na+-linked and Na+-independent
Cl-/HCO3- exchange systems in Chinese hamster lung fibro-
blasts. J. Biol. Chem., 263, 6122.
CHAPLIN, D.J. (1989). Hydralazine-induced tumour hypoxia: a
potential target for cancer chemotherapy. J. Natl Cancer Inst., 81,
618.
CHAPLIN, D.J. & ACKER, B. (1987). The effect of hydralazine on the
tumour cytotoxicity of the hypoxic cell cytotoxin RSU-1069:
evidence for therapeutic gain. Int. J. Radiat. Biol. Oncol. Phys.,
13, 579.
CHAPLIN, D.J., DURAND, R.E. & OLIVE, P.L. (1985). Cell selection
from a murine tumour using the fluorescent probe Hoechst 33342.
Br. J. Cancer, 51, 569.
DOBROWSKY, E., NEWELL, K. & TANNOCK, I.F. (1991). The poten-
tial of lactate and succinate to kill nutrient deprived tumour cells
by intracellular acidification. Int. J. Radiat. Oncol. Biol. Phys., 20,
275.
DUNN, J.F., FROSTICK, S., ADAMS, G.E., STRATFORD, I.J.,
HOWELLS, N., HOGAN, G. & RADDA, G.K. (1989). Induction of
tumour hypoxia by a vasoactive agent. A combined NMR and
radiobiological study. FEBS Lett., 249, 343.
DURAND, R.E. (1982). Use of Hoechst 33342 for cell selection from
multicell systems. J. Histochem., 30, 117.
GRINSTEIN, S., ROTIN, D. & MASON, M.J. (1989). Na+/H+ exchange
and growth factor-induced cytosolic pH changes. Role in cellular
proliferation. Biochim. Biophys. Acta., 988, 73.
LIN, J.-C. & SONG, C.W. (1990). Effects of hydralazine on the blood
flow in RIF-I tumours and normal tissues of mice. Radiat. Res.,
124, 171.
MINCHINTON, A.I., DURAND, R.E. & CHAPLIN, D.J. (1990). Inter-
mittent blood flow in the KHT sarcoma: flow cytometry studies
using Hoechst 33342. Br. J. Cancer, 62, 195.
MOULDER, J.E. & ROCKWELL, S. (1984). Hypoxic fractions of solid
tumours: experimental techniques, methods of analysis, and a
survey of existing data. Int. J. Radiat. Oncol. Biol. Phys., 10, 695.
NEWELL, K.J. & TANNOCK, I.F. (1989). Reduction of intracellular
pH as a possible mechanism for killing cells in acidic regions of
solid tumours: effects of carbonylcyanide-3-chlorophenylhydra-
zone. Cancer Res., 49, 4477.
ROTIN, D., STEELE-NORWOOD, D., GRINSTEIN, S. & TANNOCK, I.
(1989). Requirement of the Na+/H+ exchanger for tumour growth.
Cancer Res., 49, 205.
ROTIN, D., WAN, P., GRINSTEIN, S. & TANNOCK, I. (1987). Cyto-
toxicity of compounds that interfere with the regulation of intra-
cellular pH: a potential new class of anticancer drugs. Cancer
Res., 47, 1497.
TANNOCK, I.F. (1968). The relation between cell proliferation and
the vascular system in a transplanted mouse mammary tumour.
Br. J. Cancer, 22, 258.
TANNOCK, I. (1982). Response of aerobic and hypoxic cells in a
solid tumour to Adriamycin and cyclophosphamide and interac-
tion of the drugs with radiation. Cancer Res., 42, 4921.IN VIVO ACTIVITY OF AGENTS WHICH INHIBIT PHi REGULATION 317
TANNOCK, I.F. & ROTIN, D. (1989). Acid pH in tumours and its
potential for therapeutic exploitation. Cancer Res., 49, 4373.
THOMLINSON, R.H. & GRAY, L.H. (1955). The histological structure
of some human lung cancers and the possible implications for
radiotherapy. Br. J. Cancer, 9, 539.
THOMSON, J.E. & RAUTH, A.M. (1974). An in vitro assay to measure
the viability of KHT tumour cells not previously exposed to
culture conditions. Radiat. Res., 58, 262.
TOBARI, C., VAN KERSEN, I. & HAHN, G.M. (1988). Modification of
pH of normal and malignant mouse tissue by hydralazine and
glucose, with and without breathing 5% CO2 and 95% air.
Cancer Res., 48, 1543.
TRIVEDI, B. & DANFORTH, W.H. (1966). Effect of pH on the kinetics
of frog muscle phosphofructokinase. J. Biol. Chem., 241, 4110.
VALBOURG REINERTSEN, K., TONNESSEN, T.I., JACOBSEN, J.,
SANDVIG, K. & OLSNES, S. (1988). Role of chloride/bicarbonate
antiport in the control of cytosolic pH. Cell-line differences in
activity and regulation of antiport. J. Biol. Chem., 263, 11117.
VARNES, M., GLAZIER, K.G. & GRAY, C. (1989). pH-Dependent
effects of the ionophore nigericin on response of mammalian cells
to radiation and heat treatment. Radiat. Res., 117, 282.
VAUPEL, P., KALLINOWSKI, F. & OKUNIEFF, P. (1989). Blood flow,
oxygen and nutrient supply, and metabolic microenvironment of
human tumours: a review. Cancer Res., 49, 6449.
WHILLANS, D.W. & RAUTH, A.M. (1980). An experimental and
analytical study of oxygen depletion in stirred cell suspensions.
Radiat. Res., 84, 97.
WIKE-HOOLEY, J.L., HAVEMAN, J. & REINHOLD, H.S. (1984). The
relevance of tumour pH to the treatment of malignant disease.
Radiother. Oncol., 2, 343.